Free Trial

Agilent Technologies (A) Financials

Agilent Technologies logo
$140.02 +2.62 (+1.91%)
As of 09:45 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Agilent Technologies

Annual Income Statements for Agilent Technologies

This table shows Agilent Technologies' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 10/31/2015 10/31/2016 10/31/2017 10/31/2018 10/31/2019 10/31/2020 10/31/2021 10/31/2022 10/31/2023 10/31/2024 10/31/2025
Net Income / (Loss) Attributable to Common Shareholders
401 462 684 316 1,071 719 1,210 1,254 1,240 1,289 1,303
Consolidated Net Income / (Loss)
401 462 684 316 1,071 719 1,210 1,254 1,240 1,289 1,303
Net Income / (Loss) Continuing Operations
438 462 684 316 1,071 719 1,210 1,254 1,240 1,289 1,303
Total Pre-Tax Income
480 544 803 946 919 842 1,360 1,504 1,339 1,521 1,435
Total Operating Income
522 615 807 904 941 846 1,347 1,618 1,350 1,488 1,479
Total Gross Profit
2,041 2,197 2,399 2,680 2,805 2,837 3,407 3,722 3,465 3,535 3,643
Total Revenue
4,038 4,202 4,472 4,914 5,163 5,339 6,319 6,848 6,833 6,510 6,948
Operating Revenue
4,038 4,202 4,472 4,914 5,163 5,339 6,319 6,848 6,833 6,510 6,948
Total Cost of Revenue
1,997 2,005 2,073 2,234 2,358 2,502 2,912 3,126 3,368 2,975 3,305
Operating Cost of Revenue
1,997 2,005 2,073 2,234 2,358 2,502 2,912 3,126 3,368 2,975 3,305
Total Operating Expenses
1,519 1,582 1,592 1,776 1,864 1,991 2,060 2,104 2,115 2,047 2,164
Selling, General & Admin Expense
1,189 1,253 1,251 1,389 1,460 1,496 1,619 1,637 1,634 1,568 1,709
Research & Development Expense
330 329 341 387 404 495 441 467 481 479 455
Total Other Income / (Expense), net
-42 -71 -4.00 42 -22 -4.00 13 -114 -11 33 -44
Interest Expense
66 72 79 75 74 78 81 84 95 96 112
Interest & Investment Income
7.00 11 22 38 36 8.00 2.00 9.00 51 80 62
Other Income / (Expense), net
17 -10 53 79 16 66 92 -39 33 49 6.00
Income Tax Expense
42 82 119 630 -152 123 150 250 99 232 132
Basic Earnings per Share
$1.20 $1.42 $2.12 $0.98 $3.41 $2.33 $3.98 $4.19 $4.22 $4.44 $4.59
Weighted Average Basic Shares Outstanding
333M 326M 322M 321M 314M 309M 304M 299M 294M 290M 284M
Diluted Earnings per Share
$1.20 $1.40 $2.10 $0.97 $3.37 $2.30 $3.94 $4.18 $4.19 $4.43 $4.57
Weighted Average Diluted Shares Outstanding
335M 329M 326M 325M 318M 312M 307M 300M 296M 291M 285M
Weighted Average Basic & Diluted Shares Outstanding
334.20M 325.40M 322.60M 322.40M 310.18M 306.85M 302.00M 296.07M 293.00M 285.60M 283.50M
Cash Dividends to Common per Share
$0.40 $0.46 $0.53 $0.60 $0.66 $0.72 $0.78 $0.84 $0.90 $0.94 $0.99

Quarterly Income Statements for Agilent Technologies

This table shows Agilent Technologies' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026
Net Income / (Loss) Attributable to Common Shareholders
111 475 348 308 282 351 318 215 336 434 305
Consolidated Net Income / (Loss)
111 475 348 308 282 351 318 215 336 434 305
Net Income / (Loss) Continuing Operations
111 475 348 308 282 351 318 215 336 434 305
Total Pre-Tax Income
132 420 403 374 343 401 367 260 366 442 364
Total Operating Income
133 408 384 363 333 408 376 300 360 443 353
Total Gross Profit
658 915 908 856 855 916 899 866 888 990 946
Total Revenue
1,672 1,688 1,658 1,573 1,578 1,701 1,681 1,668 1,738 1,861 1,798
Operating Revenue
1,672 1,688 1,658 1,573 1,578 1,701 1,681 1,668 1,738 1,861 1,798
Total Cost of Revenue
1,014 773 750 717 723 785 782 802 850 871 852
Operating Cost of Revenue
1,014 773 750 717 723 785 782 802 850 871 852
Total Operating Expenses
525 507 524 493 522 508 523 566 528 547 593
Selling, General & Admin Expense
407 393 396 380 395 397 410 454 417 428 476
Research & Development Expense
118 114 128 113 127 111 113 112 111 119 117
Total Other Income / (Expense), net
-1.00 12 19 11 10 -7.00 -9.00 -40 6.00 -1.00 11
Interest Expense
24 22 22 20 22 32 28 29 28 27 25
Interest & Investment Income
13 17 18 19 19 24 15 14 16 17 15
Other Income / (Expense), net
10 17 23 12 13 1.00 4.00 -25 18 9.00 21
Income Tax Expense
21 -55 55 66 61 50 49 45 30 8.00 59
Basic Earnings per Share
$0.38 $1.63 $1.19 $1.05 $0.97 $1.23 $1.12 $0.75 $1.18 $1.54 $1.08
Weighted Average Basic Shares Outstanding
294M 294M 293M 293M 290M 290M 285M 285M 284M 284M 283M
Diluted Earnings per Share
$0.38 $1.60 $1.18 $1.05 $0.97 $1.23 $1.11 $0.75 $1.18 $1.53 $1.07
Weighted Average Diluted Shares Outstanding
295M 296M 294M 293M 291M 291M 287M 285M 285M 285M 284M
Weighted Average Basic & Diluted Shares Outstanding
292.59M 293.00M 293.06M 291.76M 287.33M 285.60M 285.10M 284.06M 283.50M 283.50M 282.60M
Cash Dividends to Common per Share
$0.23 $0.23 $0.24 $0.24 - $0.24 $0.25 $0.25 - - $0.26

Annual Cash Flow Statements for Agilent Technologies

This table details how cash moves in and out of Agilent Technologies' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 10/31/2015 10/31/2016 10/31/2017 10/31/2018 10/31/2019 10/31/2020 10/31/2021 10/31/2022 10/31/2023 10/31/2024 10/31/2025
Net Change in Cash & Equivalents
-1,025 286 391 -432 -866 59 43 -434 537 -261 459
Net Cash From Operating Activities
512 793 889 1,087 1,021 921 1,485 1,312 1,772 1,751 1,559
Net Cash From Continuing Operating Activities
512 793 889 1,087 1,021 921 1,485 1,312 1,772 1,751 1,559
Net Income / (Loss) Continuing Operations
401 462 684 316 1,071 719 1,210 1,254 1,240 1,289 1,303
Consolidated Net Income / (Loss)
401 462 684 316 1,071 719 1,210 1,254 1,240 1,289 1,303
Depreciation Expense
253 246 212 210 238 308 321 317 271 257 288
Non-Cash Adjustments To Reconcile Net Income
103 112 91 106 97 191 63 236 432 186 229
Changes in Operating Assets and Liabilities, net
-245 -27 -98 455 -385 -297 -109 -495 -171 19 -261
Net Cash From Investing Activities
-400 -238 -304 -705 -1,590 -147 -749 -338 -310 -1,258 -394
Net Cash From Continuing Investing Activities
-400 -238 -304 -705 -1,590 -147 -749 -338 -310 -1,258 -394
Purchase of Property, Plant & Equipment
-98 -139 -176 -177 -155 -119 -188 -291 -298 -378 -407
Acquisitions
-75 -261 -128 -516 -1,409 0.00 -547 -52 -51 -862 4.00
Purchase of Investments
0.00 -80 -1.00 -11 -23 -20 -22 -13 - -5.00 0.00
Sale of Property, Plant & Equipment
12 0.00 0.00 1.00 0.00 1.00 1.00 0.00 4.00 0.00 2.00
Divestitures
3.00 0.00 2.00 - - - 0.00 0.00 50 0.00 0.00
Sale and/or Maturity of Investments
0.00 1.00 - - 0.00 0.00 12 22 5.00 0.00 8.00
Other Investing Activities, net
-242 241 -1.00 -2.00 -3.00 -9.00 -5.00 -4.00 -20 -13 -1.00
Net Cash From Financing Activities
-1,089 -268 -202 -797 -299 -717 -696 -1,372 -930 -752 -715
Net Cash From Continuing Financing Activities
-1,089 -268 -202 -797 -299 -717 -696 -1,372 -930 -752 -715
Repayment of Debt
0.00 -294 -290 -693 -706 -1,766 -424 -609 -35 -569 -45
Repurchase of Common Equity
-267 -434 -194 -422 -723 -469 -788 -1,139 -575 -1,153 -435
Payment of Dividends
-133 -150 -170 -191 -210 -222 -236 -250 -265 -274 -282
Issuance of Debt
0.00 554 400 483 1,302 1,717 773 635 0.00 1,197 4.00
Issuance of Common Equity
58 62 66 56 54 60 55 58 67 77 72
Other Financing Activities, net
-747 -6.00 -14 -30 -16 -37 -76 -67 -122 -30 -29
Other Net Changes in Cash
- - - - - - - - 5.00 -2.00 9.00
Cash Interest Paid
71 73 82 80 80 71 76 85 89 80 101
Cash Income Taxes Paid
129 67 63 102 159 361 211 279 199 314 318

Quarterly Cash Flow Statements for Agilent Technologies

This table details how cash moves in and out of Agilent Technologies' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026
Net Change in Cash & Equivalents
154 261 157 -76 108 -450 138 19 48 254 -31
Net Cash From Operating Activities
562 516 485 333 452 481 431 221 362 545 268
Net Cash From Continuing Operating Activities
562 516 485 333 452 481 431 221 362 545 268
Net Income / (Loss) Continuing Operations
111 475 348 308 282 351 318 215 336 434 305
Consolidated Net Income / (Loss)
111 475 348 308 282 351 318 215 336 434 305
Depreciation Expense
71 62 62 63 63 69 72 73 72 71 67
Non-Cash Adjustments To Reconcile Net Income
319 14 54 44 42 46 49 87 43 50 51
Changes in Operating Assets and Liabilities, net
61 -35 21 -82 65 15 -8.00 -154 -89 -10 -155
Net Cash From Investing Activities
-89 -40 -95 -109 -100 -954 -94 -114 -96 -90 -93
Net Cash From Continuing Investing Activities
-89 -40 -95 -109 -100 -954 -94 -114 -96 -90 -93
Purchase of Property, Plant & Equipment
-81 -84 -90 -103 -92 -93 -97 -114 -103 -93 -93
Acquisitions
- - 0.00 - -3.00 -859 4.00 - - - 0.00
Other Investing Activities, net
-6.00 -9.00 -5.00 -3.00 -3.00 -2.00 -1.00 - - - 0.00
Net Cash From Financing Activities
-322 -201 -240 -291 -246 25 -180 -116 -219 -200 -222
Net Cash From Continuing Financing Activities
-322 -201 -240 -291 -246 28 -180 -116 -219 -200 -222
Repayment of Debt
- -35 -180 - - -429 -31 130 -88 -56 -2.00
Repurchase of Common Equity
-335 -80 0.00 -230 -585 -335 -90 -175 -85 -85 -152
Payment of Dividends
-66 -66 -69 -69 -68 -68 -71 -70 -71 -70 -72
Issuance of Debt
55 -20 0.00 - 375 862 4.00 - - - 0.00
Issuance of Common Equity
30 2.00 34 9.00 33 1.00 30 1.00 29 12 31
Other Financing Activities, net
-6.00 -2.00 -25 -1.00 -1.00 -3.00 -22 -2.00 -4.00 -1.00 -27
Other Net Changes in Cash
- - 7.00 - - - -19 28 1.00 -1.00 16
Cash Interest Paid
16 29 14 26 10 30 3.00 48 4.00 46 1.00
Cash Income Taxes Paid
15 56 24 200 60 30 19 229 56 14 105

Annual Balance Sheets for Agilent Technologies

This table presents Agilent Technologies' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 10/31/2015 10/31/2016 10/31/2017 10/31/2018 10/31/2019 10/31/2020 10/31/2021 10/31/2022 10/31/2023 10/31/2024 10/31/2025
Total Assets
7,479 7,794 8,426 8,541 9,452 9,627 10,705 10,532 10,763 11,846 12,727
Total Current Assets
3,686 3,635 4,169 3,848 3,189 3,415 3,799 3,778 4,186 3,959 4,594
Cash & Equivalents
2,003 2,289 2,678 2,247 1,382 1,441 1,484 1,053 1,590 1,329 1,789
Accounts Receivable
606 631 724 776 930 1,038 1,172 1,405 1,291 1,324 1,487
Inventories, net
541 533 575 638 679 720 830 1,038 1,031 972 1,025
Other Current Assets
294 182 192 187 198 216 222 282 274 334 293
Plant, Property, & Equipment, net
604 639 757 822 850 845 945 1,100 1,270 1,778 2,023
Total Noncurrent Assets
3,189 3,520 3,500 3,871 5,413 5,367 5,961 5,654 5,307 6,109 6,110
Long-Term Investments
86 135 138 68 102 158 185 195 164 175 133
Goodwill
2,366 2,517 2,607 2,973 3,593 3,602 3,975 3,952 3,960 4,477 4,473
Intangible Assets
445 416 361 491 1,107 831 981 821 475 547 445
Other Noncurrent Operating Assets
292 452 394 339 611 776 820 686 708 910 1,059
Total Liabilities & Shareholders' Equity
7,479 7,794 8,426 8,541 9,452 9,627 10,705 10,532 10,763 11,846 12,727
Total Liabilities
3,309 3,548 3,591 3,970 4,704 4,754 5,316 5,227 4,918 5,948 5,986
Total Current Liabilities
976 945 1,263 1,171 2,080 1,467 1,708 1,861 1,603 1,895 2,347
Short-Term Debt
- 0.00 210 0.00 616 75 0.00 36 0.00 45 304
Accounts Payable
279 257 305 340 354 354 446 580 418 540 570
Accrued Expenses
- - - - - - - - - - 406
Current Deferred Revenue
258 269 291 324 336 386 441 461 505 544 624
Current Employee Benefit Liabilities
221 235 276 304 334 367 493 455 371 368 443
Total Noncurrent Liabilities
2,333 2,603 2,328 2,799 2,624 3,287 3,608 3,366 3,315 4,053 3,639
Long-Term Debt
1,655 1,904 1,801 1,799 1,791 2,284 2,729 2,733 2,735 3,345 3,050
Noncurrent Employee Benefit Liabilities
264 360 234 239 360 389 220 97 103 130 126
Other Noncurrent Operating Liabilities
414 339 293 761 473 614 659 536 477 578 463
Commitments & Contingencies
- - - - 0.00 - 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
4,170 4,246 4,835 4,571 4,748 4,873 5,389 5,305 5,845 5,898 6,741
Total Preferred & Common Equity
4,167 4,243 4,831 4,567 4,748 4,873 5,389 5,305 5,845 5,898 6,741
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
4,167 4,243 4,831 4,567 4,748 4,873 5,389 5,305 5,845 5,898 6,741
Common Stock
9,051 9,165 5,303 5,311 5,280 5,314 5,323 5,328 5,390 5,453 5,578
Retained Earnings
5,581 6,089 -126 -336 -18 81 348 324 782 750 1,389
Accumulated Other Comprehensive Income / (Loss)
-391 -503 -346 -408 -514 -522 -282 -347 -327 -305 -226

Quarterly Balance Sheets for Agilent Technologies

This table presents Agilent Technologies' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 4/30/2023 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 1/31/2026
Total Assets
10,792 10,675 10,763 10,948 10,856 10,996 11,846 11,914 12,158 12,226 12,813
Total Current Assets
3,949 4,030 4,186 4,338 4,203 4,256 3,959 4,107 4,208 4,253 4,615
Cash & Equivalents
1,175 1,329 1,590 1,748 1,671 1,779 1,329 1,467 1,486 1,535 1,758
Accounts Receivable
1,401 1,339 1,291 1,295 1,249 1,227 1,324 1,328 1,366 1,382 1,521
Inventories, net
1,103 1,072 1,031 1,033 1,000 978 972 997 991 1,014 1,059
Other Current Assets
270 290 274 262 283 272 334 315 365 322 277
Plant, Property, & Equipment, net
1,184 1,211 1,270 1,314 1,371 1,446 1,778 1,816 1,912 1,966 2,078
Total Noncurrent Assets
5,659 5,434 5,307 5,296 5,282 5,294 6,109 5,991 6,038 6,007 6,120
Long-Term Investments
186 190 164 170 177 186 175 173 135 133 135
Goodwill
3,980 3,984 3,960 3,967 3,963 3,965 4,477 4,429 4,474 4,475 4,484
Intangible Assets
798 502 475 443 417 392 547 514 495 469 426
Other Noncurrent Operating Assets
695 758 708 716 725 751 910 875 934 930 1,075
Total Liabilities & Shareholders' Equity
10,792 10,675 10,763 10,948 10,856 10,996 11,846 11,914 12,158 12,226 12,813
Total Liabilities
5,011 5,117 4,918 4,760 4,642 5,093 5,948 5,887 6,022 5,856 5,905
Total Current Liabilities
1,666 1,760 1,603 1,617 1,958 2,389 1,895 1,869 2,012 1,892 2,234
Short-Term Debt
0.00 55 0.00 - 420 795 45 16 146 59 304
Accounts Payable
479 452 418 488 461 497 540 547 517 530 602
Accrued Expenses
309 410 - 335 218 264 398 436 374 337 349
Current Deferred Revenue
519 512 505 522 533 524 544 612 628 620 682
Current Employee Benefit Liabilities
359 331 371 272 326 309 368 258 347 346 297
Total Noncurrent Liabilities
3,345 3,357 3,315 3,143 2,684 2,704 4,053 4,018 4,010 3,964 3,671
Long-Term Debt
2,733 2,734 2,735 2,555 2,136 2,137 3,345 3,347 3,349 3,350 3,050
Noncurrent Employee Benefit Liabilities
97 92 103 102 99 96 130 120 126 119 130
Other Noncurrent Operating Liabilities
515 531 477 486 449 471 578 551 535 495 491
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
5,781 5,558 5,845 6,188 6,214 5,903 5,898 6,027 6,136 6,370 6,908
Total Preferred & Common Equity
5,781 5,558 5,845 6,188 6,214 5,903 5,898 6,027 6,136 6,370 6,908
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
5,781 5,558 5,845 6,188 6,214 5,903 5,898 6,027 6,136 6,370 6,908
Common Stock
5,363 5,385 5,390 5,443 5,461 5,461 5,453 5,492 5,504 5,551 5,608
Retained Earnings
700 444 782 1,061 1,090 773 750 916 912 1,102 1,484
Accumulated Other Comprehensive Income / (Loss)
-282 -271 -327 -316 -337 -331 -305 -381 -280 -283 -184

Annual Metrics And Ratios for Agilent Technologies

This table displays calculated financial ratios and metrics derived from Agilent Technologies' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 10/31/2015 10/31/2016 10/31/2017 10/31/2018 10/31/2019 10/31/2020 10/31/2021 10/31/2022 10/31/2023 10/31/2024 10/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-0.25% 4.06% 6.43% 9.88% 5.07% 3.41% 18.36% 8.37% -0.22% -4.73% 6.73%
EBITDA Growth
14.45% 7.45% 25.97% 11.29% 0.17% 2.09% 44.26% 7.73% -12.76% 8.46% -1.17%
EBIT Growth
63.33% 12.24% 42.15% 14.30% -2.65% -4.70% 57.79% 9.73% -12.41% 11.14% -3.38%
NOPAT Growth
12.21% 9.65% 31.61% -56.07% 263.16% -34.12% 65.89% 12.57% -7.33% 0.87% 6.50%
Net Income Growth
-26.96% 15.21% 48.05% -53.80% 238.92% -32.87% 68.29% 3.64% -1.12% 3.95% 1.09%
EPS Growth
-25.93% 16.67% 50.00% -53.81% 247.42% -31.75% 71.30% 6.09% 0.24% 5.73% 3.16%
Operating Cash Flow Growth
-29.96% 54.88% 12.11% 22.27% -6.07% -9.79% 61.24% -11.65% 35.06% -1.19% -10.97%
Free Cash Flow Firm Growth
-62.10% -59.07% 32.07% -27.76% -287.52% 246.41% -37.74% 86.10% 41.90% -75.76% 214.80%
Invested Capital Growth
-6.25% 6.64% 8.16% 0.62% 39.85% -0.67% 12.87% 7.36% 0.00% 14.03% 5.00%
Revenue Q/Q Growth
-0.20% 1.84% 1.78% 2.18% 1.43% 2.22% 2.88% 2.84% -2.30% 0.20% 2.36%
EBITDA Q/Q Growth
18.92% 0.59% 6.77% 1.45% 1.19% 4.72% 11.04% -0.32% -3.44% -0.50% 2.60%
EBIT Q/Q Growth
41.84% 1.51% 9.14% 1.34% -0.62% 6.42% 13.13% 0.32% -3.35% -1.03% 2.98%
NOPAT Q/Q Growth
12.46% 0.02% -0.05% 9.47% 1.97% 3.63% 15.64% -1.38% 7.30% -7.64% 6.27%
Net Income Q/Q Growth
21.88% -2.94% 8.06% 6.04% -0.09% 4.05% 22.22% -5.57% 9.44% -8.78% 6.80%
EPS Q/Q Growth
21.21% -4.11% 6.60% 6.59% 0.90% 3.60% 23.13% -4.78% 9.40% -7.71% 7.03%
Operating Cash Flow Q/Q Growth
12.53% -0.88% 6.47% 8.37% -5.38% 7.34% 4.50% 0.54% 3.99% -1.96% 4.28%
Free Cash Flow Firm Q/Q Growth
-66.64% 20.37% -33.29% 171.96% -192.67% 281.10% -28.53% 9.05% 16.93% -77.10% 4,091.55%
Invested Capital Q/Q Growth
-2.89% -3.94% 0.95% -2.66% 21.15% -2.85% 3.01% 1.40% -0.03% 13.30% 0.76%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
50.54% 52.28% 53.64% 54.54% 54.33% 53.14% 53.92% 54.35% 50.71% 54.30% 52.43%
EBITDA Margin
19.61% 20.25% 23.97% 24.28% 23.15% 22.85% 27.85% 27.69% 24.21% 27.56% 25.52%
Operating Margin
12.93% 14.64% 18.05% 18.40% 18.23% 15.85% 21.32% 23.63% 19.76% 22.86% 21.29%
EBIT Margin
13.35% 14.40% 19.23% 20.00% 18.54% 17.08% 22.77% 23.06% 20.24% 23.61% 21.37%
Profit (Net Income) Margin
9.93% 10.99% 15.30% 6.43% 20.74% 13.47% 19.15% 18.31% 18.15% 19.80% 18.75%
Tax Burden Percent
83.54% 84.93% 85.18% 33.40% 116.54% 85.39% 88.97% 83.38% 92.61% 84.75% 90.80%
Interest Burden Percent
89.05% 89.92% 93.37% 96.24% 96.03% 92.32% 94.51% 95.25% 96.82% 98.96% 96.63%
Effective Tax Rate
8.75% 15.07% 14.82% 66.60% -16.54% 14.61% 11.03% 16.62% 7.39% 15.25% 9.20%
Return on Invested Capital (ROIC)
13.19% 14.47% 17.73% 7.47% 22.55% 12.78% 19.99% 20.47% 18.32% 17.26% 16.83%
ROIC Less NNEP Spread (ROIC-NNEP)
19.88% 24.55% 18.24% 5.35% 9.95% 12.38% 21.33% 12.83% 17.50% 19.21% 14.42%
Return on Net Nonoperating Assets (RNNOA)
-4.73% -3.49% -2.66% -0.75% 0.43% 2.16% 3.59% 2.99% 3.93% 4.69% 3.79%
Return on Equity (ROE)
8.47% 10.98% 15.06% 6.72% 22.99% 14.95% 23.58% 23.45% 22.24% 21.95% 20.62%
Cash Return on Invested Capital (CROIC)
19.65% 8.04% 9.89% 6.85% -10.68% 13.45% 7.90% 13.37% 18.32% 4.15% 11.96%
Operating Return on Assets (OROA)
5.89% 7.92% 10.60% 11.59% 10.64% 9.56% 14.16% 14.87% 12.99% 13.60% 12.09%
Return on Assets (ROA)
4.38% 6.05% 8.43% 3.72% 11.90% 7.54% 11.90% 11.81% 11.65% 11.40% 10.61%
Return on Common Equity (ROCE)
8.46% 10.97% 15.05% 6.71% 22.98% 14.95% 23.58% 23.45% 22.24% 21.95% 20.62%
Return on Equity Simple (ROE_SIMPLE)
9.62% 10.89% 14.16% 6.92% 22.56% 14.75% 22.45% 23.64% 21.21% 21.85% 0.00%
Net Operating Profit after Tax (NOPAT)
476 522 687 302 1,097 722 1,198 1,349 1,250 1,261 1,343
NOPAT Margin
11.80% 12.43% 15.37% 6.15% 21.24% 13.53% 18.97% 19.70% 18.30% 19.37% 19.33%
Net Nonoperating Expense Percent (NNEP)
-6.69% -10.08% -0.51% 2.12% 12.60% 0.41% -1.34% 7.63% 0.81% -1.95% 2.41%
Return On Investment Capital (ROIC_SIMPLE)
8.18% 8.49% 10.04% 4.74% 15.33% 9.99% 14.76% 16.71% 14.57% 13.58% 13.30%
Cost of Revenue to Revenue
49.46% 47.72% 46.36% 45.46% 45.67% 46.86% 46.08% 45.65% 49.29% 45.70% 47.57%
SG&A Expenses to Revenue
29.45% 29.82% 27.97% 28.27% 28.28% 28.02% 25.62% 23.90% 23.91% 24.09% 24.60%
R&D to Revenue
8.17% 7.83% 7.63% 7.88% 7.82% 9.27% 6.98% 6.82% 7.04% 7.36% 6.55%
Operating Expenses to Revenue
37.62% 37.65% 35.60% 36.14% 36.10% 37.29% 32.60% 30.72% 30.95% 31.44% 31.15%
Earnings before Interest and Taxes (EBIT)
539 605 860 983 957 912 1,439 1,579 1,383 1,537 1,485
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
792 851 1,072 1,193 1,195 1,220 1,760 1,896 1,654 1,794 1,773
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.79 3.13 4.29 4.32 4.76 6.28 8.65 7.60 5.13 6.34 6.16
Price to Tangible Book Value (P/TBV)
8.57 10.12 11.13 17.90 470.97 69.58 107.71 75.79 21.27 42.76 22.76
Price to Revenue (P/Rev)
2.88 3.16 4.64 4.02 4.38 5.73 7.38 5.89 4.39 5.74 5.97
Price to Earnings (P/E)
28.97 28.70 30.32 62.47 21.11 42.58 38.54 32.15 24.18 28.99 31.84
Dividend Yield
1.14% 1.13% 0.82% 0.96% 0.90% 0.73% 0.50% 0.62% 0.88% 0.73% 0.68%
Earnings Yield
3.45% 3.48% 3.30% 1.60% 4.74% 2.35% 2.59% 3.11% 4.14% 3.45% 3.14%
Enterprise Value to Invested Capital (EV/IC)
3.13 3.42 4.95 4.74 4.15 5.57 7.49 6.13 4.54 5.04 5.25
Enterprise Value to Revenue (EV/Rev)
2.71 3.03 4.46 3.91 4.56 5.88 7.53 6.11 4.53 6.03 6.18
Enterprise Value to EBITDA (EV/EBITDA)
13.82 14.97 18.60 16.12 19.69 25.72 27.05 22.07 18.72 21.88 24.21
Enterprise Value to EBIT (EV/EBIT)
20.30 21.06 23.19 19.56 24.59 34.40 33.08 26.50 22.39 25.54 28.91
Enterprise Value to NOPAT (EV/NOPAT)
22.97 24.40 29.01 63.68 21.46 43.43 39.72 31.02 24.77 31.13 31.96
Enterprise Value to Operating Cash Flow (EV/OCF)
21.37 16.07 22.43 17.69 23.05 34.07 32.06 31.89 17.48 22.42 27.53
Enterprise Value to Free Cash Flow (EV/FCFF)
15.43 43.90 52.01 69.43 0.00 41.26 100.55 47.49 24.77 129.55 45.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.40 0.45 0.42 0.39 0.51 0.48 0.51 0.52 0.47 0.57 0.50
Long-Term Debt to Equity
0.40 0.45 0.37 0.39 0.38 0.47 0.51 0.52 0.47 0.57 0.45
Financial Leverage
-0.24 -0.14 -0.15 -0.14 0.04 0.17 0.17 0.23 0.22 0.24 0.26
Leverage Ratio
1.93 1.81 1.79 1.80 1.93 1.98 1.98 1.99 1.91 1.93 1.94
Compound Leverage Factor
1.72 1.63 1.67 1.74 1.85 1.83 1.87 1.89 1.85 1.91 1.88
Debt to Total Capital
28.41% 30.96% 29.37% 28.24% 33.64% 32.62% 33.62% 34.30% 31.88% 36.50% 33.22%
Short-Term Debt to Total Capital
0.00% 0.00% 3.07% 0.00% 8.61% 1.04% 0.00% 0.45% 0.00% 0.48% 3.01%
Long-Term Debt to Total Capital
28.41% 30.96% 26.31% 28.24% 25.03% 31.58% 33.62% 33.85% 31.88% 36.01% 30.21%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.05% 0.05% 0.06% 0.06% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
71.54% 68.99% 70.57% 71.70% 66.36% 67.38% 66.38% 65.70% 68.12% 63.50% 66.78%
Debt to EBITDA
2.09 2.24 1.88 1.51 2.01 1.93 1.55 1.46 1.65 1.89 1.89
Net Debt to EBITDA
-0.85 -0.61 -0.75 -0.43 0.77 0.62 0.55 0.80 0.59 1.05 0.81
Long-Term Debt to EBITDA
2.09 2.24 1.68 1.51 1.50 1.87 1.55 1.44 1.65 1.86 1.72
Debt to NOPAT
3.47 3.65 2.93 5.96 2.19 3.27 2.28 2.05 2.19 2.69 2.50
Net Debt to NOPAT
-1.42 -1.00 -1.17 -1.71 0.84 1.05 0.81 1.13 0.78 1.50 1.07
Long-Term Debt to NOPAT
3.47 3.65 2.62 5.96 1.63 3.16 2.28 2.03 2.19 2.65 2.27
Altman Z-Score
4.36 4.55 4.73 4.26 3.90 4.99 6.58 6.03 5.11 5.05 5.45
Noncontrolling Interest Sharing Ratio
0.06% 0.07% 0.08% 0.09% 0.04% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
3.78 3.85 3.30 3.29 1.53 2.33 2.22 2.03 2.61 2.09 1.96
Quick Ratio
2.67 3.09 2.69 2.58 1.11 1.69 1.61 1.32 1.80 1.40 1.40
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
709 290 383 277 -519 760 473 881 1,250 303 954
Operating Cash Flow to CapEx
595.35% 570.50% 505.11% 617.61% 658.71% 780.51% 794.12% 450.86% 602.72% 463.23% 384.94%
Free Cash Flow to Firm to Interest Expense
10.75 4.03 4.85 3.69 -7.02 9.75 5.84 10.49 13.16 3.16 8.52
Operating Cash Flow to Interest Expense
7.76 11.01 11.25 14.49 13.80 11.81 18.33 15.62 18.65 18.24 13.92
Operating Cash Flow Less CapEx to Interest Expense
6.45 9.08 9.03 12.15 11.70 10.29 16.02 12.15 15.56 14.30 10.30
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.44 0.55 0.55 0.58 0.57 0.56 0.62 0.64 0.64 0.58 0.57
Accounts Receivable Turnover
6.56 6.79 6.60 6.55 6.05 5.43 5.72 5.31 5.07 4.98 4.94
Inventory Turnover
3.58 3.73 3.74 3.68 3.58 3.58 3.76 3.35 3.26 2.97 3.31
Fixed Asset Turnover
6.54 6.76 6.41 6.22 6.18 6.30 7.06 6.70 5.77 4.27 3.66
Accounts Payable Turnover
6.87 7.48 7.38 6.93 6.80 7.07 7.28 6.09 6.75 6.21 5.96
Days Sales Outstanding (DSO)
55.68 53.73 55.30 55.71 60.30 67.27 63.83 68.68 72.01 73.31 73.84
Days Inventory Outstanding (DIO)
101.90 97.76 97.54 99.09 101.93 102.05 97.14 109.06 112.11 122.87 110.27
Days Payable Outstanding (DPO)
53.10 48.79 49.48 52.69 53.71 51.64 50.14 59.90 54.08 58.77 61.29
Cash Conversion Cycle (CCC)
104.48 102.70 103.36 102.11 108.52 117.67 110.83 117.83 130.04 137.41 122.81
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
3,494 3,726 4,030 4,055 5,671 5,633 6,358 6,826 6,826 7,784 8,173
Invested Capital Turnover
1.12 1.16 1.15 1.22 1.06 0.94 1.05 1.04 1.00 0.89 0.87
Increase / (Decrease) in Invested Capital
-233 232 304 25 1,616 -38 725 468 0.00 958 389
Enterprise Value (EV)
10,942 12,743 19,939 19,229 23,530 31,374 47,606 41,842 30,967 39,259 42,925
Market Capitalization
11,615 13,260 20,740 19,741 22,607 30,614 46,637 40,321 29,986 37,373 41,493
Book Value per Share
$12.57 $13.08 $15.01 $14.33 $15.34 $15.81 $17.80 $17.92 $19.98 $20.53 $23.78
Tangible Book Value per Share
$4.09 $4.04 $5.79 $3.46 $0.16 $1.43 $1.43 $1.80 $4.82 $3.04 $6.43
Total Capital
5,825 6,150 6,846 6,370 7,155 7,232 8,118 8,074 8,580 9,288 10,095
Total Debt
1,655 1,904 2,011 1,799 2,407 2,359 2,729 2,769 2,735 3,390 3,354
Total Long-Term Debt
1,655 1,904 1,801 1,799 1,791 2,284 2,729 2,733 2,735 3,345 3,050
Net Debt
-676 -520 -805 -516 923 760 969 1,521 981 1,886 1,432
Capital Expenditures (CapEx)
86 139 176 176 155 118 187 291 294 378 405
Debt-free, Cash-free Net Working Capital (DFCFNWC)
465 401 438 430 343 582 516 900 993 780 762
Debt-free Net Working Capital (DFNWC)
2,710 2,690 3,116 2,677 1,725 2,023 2,091 1,953 2,583 2,109 2,551
Net Working Capital (NWC)
2,710 2,690 2,906 2,677 1,109 1,948 2,091 1,917 2,583 2,064 2,247
Net Nonoperating Expense (NNE)
75 60 3.41 -14 26 3.42 -12 95 10 -28 40
Net Nonoperating Obligations (NNO)
-676 -520 -805 -516 923 760 969 1,521 981 1,886 1,432
Total Depreciation and Amortization (D&A)
253 246 212 210 238 308 321 317 271 257 288
Debt-free, Cash-free Net Working Capital to Revenue
11.52% 9.54% 9.79% 8.75% 6.64% 10.90% 8.17% 13.14% 14.53% 11.98% 10.97%
Debt-free Net Working Capital to Revenue
67.11% 64.02% 69.68% 54.48% 33.41% 37.89% 33.09% 28.52% 37.80% 32.40% 36.72%
Net Working Capital to Revenue
67.11% 64.02% 64.98% 54.48% 21.48% 36.49% 33.09% 27.99% 37.80% 31.71% 32.34%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.20 $1.42 $2.12 $0.98 $3.41 $2.33 $3.98 $4.19 $4.22 $4.44 $4.59
Adjusted Weighted Average Basic Shares Outstanding
333M 326M 322M 321M 314M 309M 304M 299M 294M 290M 284M
Adjusted Diluted Earnings per Share
$1.20 $1.40 $2.10 $0.97 $3.37 $2.30 $3.94 $4.18 $4.19 $4.43 $4.57
Adjusted Weighted Average Diluted Shares Outstanding
335M 329M 326M 325M 318M 312M 307M 300M 296M 291M 285M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $3.41 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
332.17M 321.75M 323.02M 318.53M 310.18M 306.85M 302.00M 296.07M 293.00M 285.60M 283.50M
Normalized Net Operating Profit after Tax (NOPAT)
476 522 687 633 659 722 1,198 1,349 1,250 1,261 1,343
Normalized NOPAT Margin
11.80% 12.43% 15.37% 12.88% 12.76% 13.53% 18.97% 19.70% 18.30% 19.37% 19.33%
Pre Tax Income Margin
11.89% 12.95% 17.96% 19.25% 17.80% 15.77% 21.52% 21.96% 19.60% 23.36% 20.65%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
8.17 8.40 10.89 13.11 12.93 11.69 17.77 18.80 14.56 16.01 13.26
NOPAT to Interest Expense
7.22 7.25 8.70 4.03 14.82 9.26 14.80 16.06 13.16 13.14 11.99
EBIT Less CapEx to Interest Expense
6.86 6.47 8.66 10.76 10.84 10.18 15.46 15.33 11.46 12.07 9.64
NOPAT Less CapEx to Interest Expense
5.91 5.32 6.47 1.68 12.72 7.75 12.49 12.60 10.07 9.20 8.37
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
33.17% 32.47% 24.85% 60.44% 19.61% 30.88% 19.50% 19.94% 21.37% 21.26% 21.64%
Augmented Payout Ratio
99.75% 126.41% 53.22% 193.99% 87.11% 96.11% 84.63% 110.77% 67.74% 110.47% 55.03%

Quarterly Metrics And Ratios for Agilent Technologies

This table displays calculated financial ratios and metrics derived from Agilent Technologies' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026
DEI Shares Outstanding
- - - - - - - - - - 283,498,871.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 283,498,871.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 1.08
Growth Metrics
- - - - - - - - - - -
Profitability Metrics
- - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)
112 461 332 299 274 357 326 248 330 435 296
Return On Investment Capital (ROIC_SIMPLE)
1.34% 5.38% 3.79% 3.41% 3.10% 3.85% 3.47% 2.58% 3.38% 4.31% 2.88%
Earnings before Interest and Taxes (EBIT)
143 425 407 375 346 409 380 275 378 452 374
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
214 487 469 438 409 478 452 348 450 523 441
Valuation Ratios
- - - - - - - - - - -
Leverage & Solvency
- - - - - - - - - - -
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
16 461 649 530 232 -601 -599 -840 -911 46 -323
Efficiency Ratios
- - - - - - - - - - -
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
6,828 6,826 6,825 6,922 6,870 7,784 7,750 8,010 8,111 8,173 8,369
Increase / (Decrease) in Invested Capital
96 0.00 -317 -231 42 958 925 1,088 1,241 389 619
Book Value per Share
$18.82 $19.98 $21.12 $21.20 $20.23 $20.53 $21.10 $21.52 $22.42 $23.78 $24.37
Tangible Book Value per Share
$3.63 $4.82 $6.07 $6.26 $5.30 $3.04 $3.80 $4.09 $5.02 $6.43 $7.05
Total Capital
8,347 8,580 8,743 8,770 8,835 9,288 9,390 9,631 9,779 10,095 10,262
Total Debt
2,789 2,735 2,555 2,556 2,932 3,390 3,363 3,495 3,409 3,354 3,354
Total Long-Term Debt
2,734 2,735 2,555 2,136 2,137 3,345 3,347 3,349 3,350 3,050 3,050
Net Debt
1,270 981 637 708 967 1,886 1,723 1,874 1,741 1,432 1,461
Capital Expenditures (CapEx)
81 84 90 103 92 93 97 114 103 93 93
Debt-free, Cash-free Net Working Capital (DFCFNWC)
996 993 973 994 883 780 787 856 885 762 927
Debt-free Net Working Capital (DFNWC)
2,325 2,583 2,721 2,665 2,662 2,109 2,254 2,342 2,420 2,551 2,685
Net Working Capital (NWC)
2,270 2,583 2,721 2,245 1,867 2,064 2,238 2,196 2,361 2,247 2,381
Net Nonoperating Expense (NNE)
0.84 -14 -16 -9.06 -8.22 6.13 7.80 33 -5.51 0.98 -9.22
Net Nonoperating Obligations (NNO)
1,270 981 637 708 967 1,886 1,723 1,874 1,741 1,432 1,461
Total Depreciation and Amortization (D&A)
71 62 62 63 63 69 72 73 72 71 67
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.38 $1.63 $1.19 $1.05 $0.97 $1.23 $1.12 $0.75 $1.18 $1.54 $1.08
Adjusted Weighted Average Basic Shares Outstanding
294M 294M 293M 293M 290M 290M 285M 285M 284M 284M 283M
Adjusted Diluted Earnings per Share
$0.38 $1.60 $1.18 $1.05 $0.97 $1.23 $1.11 $0.75 $1.18 $1.53 $1.07
Adjusted Weighted Average Diluted Shares Outstanding
295M 296M 294M 293M 291M 291M 287M 285M 285M 285M 284M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
292.59M 293.00M 293.06M 291.76M 287.33M 285.60M 285.10M 284.06M 283.50M 283.50M 282.60M
Normalized Net Operating Profit after Tax (NOPAT)
112 286 332 299 274 357 326 248 330 435 296
Debt Service Ratios
- - - - - - - - - - -
Payout Ratios
- - - - - - - - - - -

Financials Breakdown Chart

Key Financial Trends

Agilent Technologies’ latest quarter shows solid profitability and strong operating cash flow, but revenue growth remains modest and the company is still spending heavily on buybacks, dividends, and debt management. Over the past several years, Agilent has generally maintained healthy margins, consistent earnings, and reliable cash generation. However, the trend in recent quarters points to slower top-line growth, some pressure in operating cash flow from working capital, and a balance sheet that remains leveraged.

What stands out in Q1 2026 is that revenue slipped to $1.798 billion from $1.861 billion in Q4 2025 and was only slightly above the prior-year comparable quarter. Net income came in at $305 million, down from $434 million in the prior quarter and modestly below some of the stronger periods in 2024 and 2025. Even so, the company generated $268 million in operating cash flow, which is a positive sign for a business of this size.

Looking at the longer trend, Agilent has remained profitable through the cycle. Quarterly revenue has mostly ranged from about $1.57 billion to $1.86 billion over the last four years, while net income has typically stayed in the low-to-mid hundreds of millions per quarter. Gross margins and operating margins have generally been respectable, and the company has shown an ability to pass through at least some cost pressure. That said, the pace of growth has not been especially fast, and quarterly results have been choppy.

Cash flow remains a key strength. In Q1 2026, operating cash flow of $268 million easily covered capital spending of $93 million, leaving free cash flow that appears healthy even after dividends and repurchases. Across the recent history provided, Agilent has regularly produced positive operating cash flow, often well above $300 million per quarter in stronger periods. This supports ongoing capital returns to shareholders.

The balance sheet is manageable, but leverage is still meaningful. As of Q1 2026, Agilent had $1.76 billion in cash and equivalents against $3.05 billion in long-term debt and $304 million in short-term debt. Total liabilities were $5.91 billion versus $6.91 billion in common equity. That is not a distressed balance sheet, but it does leave the company with enough debt to watch if growth slows or margins compress.

  • Consistent profitability: Agilent has stayed solidly profitable across the last four years, with net income regularly in the hundreds of millions per quarter.
  • Healthy operating cash flow: Q1 2026 operating cash flow of $268 million shows the business still converts earnings into cash.
  • Free cash flow generation: Capital spending remains manageable relative to operating cash flow, supporting shareholder returns.
  • Strong liquidity: Cash and equivalents of $1.76 billion provide a sizeable cushion.
  • Ongoing capital returns: The company continues to repurchase shares and pay dividends, signaling confidence in cash generation.
  • Revenue growth is modest: Recent quarterly revenue has been mostly flat to slightly higher year over year, but not accelerating meaningfully.
  • Margins remain respectable: Gross margin and operating income have generally held up, but there is no clear breakout in profitability.
  • Working capital can be volatile: Q1 2026 saw a $155 million drag from changes in operating assets and liabilities, which can swing cash flow quarter to quarter.
  • Balance sheet is stable but not ultra-conservative: Debt remains material, though not alarming relative to earnings power.
  • Sequential earnings slowdown: Q1 2026 net income fell from the prior quarter’s $434 million to $305 million.
  • Operating cash flow declined from Q4 2025: CFO fell to $268 million from $545 million, largely due to working capital pressure.
  • Heavy buybacks and dividends consume cash: In Q1 2026, Agilent spent $152 million on repurchases and $72 million on dividends, which reduces flexibility.
  • Meaningful debt load: Long-term debt of $3.05 billion limits financial flexibility compared with a net-cash balance sheet.

Bottom line: Agilent looks like a steady, cash-generative healthcare/life-science tools company rather than a rapid-growth story. The financials suggest resilience, but investors should expect moderate growth and watch for continued pressure from working capital, debt, and the size of capital returns relative to earnings.

06/04/26 09:45 AM ETAI Generated. May Contain Errors.

Agilent Technologies Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Agilent Technologies' financial year ends in October. Their financial year 2025 ended on October 31, 2025.

Agilent Technologies' net income appears to be on an upward trend, with a most recent value of $1.30 billion in 2025, rising from $401 million in 2015. The previous period was $1.29 billion in 2024. Check out Agilent Technologies' forecast to explore projected trends and price targets.

Agilent Technologies' total operating income in 2025 was $1.48 billion, based on the following breakdown:
  • Total Gross Profit: $3.64 billion
  • Total Operating Expenses: $2.16 billion

Over the last 10 years, Agilent Technologies' total revenue changed from $4.04 billion in 2015 to $6.95 billion in 2025, a change of 72.1%.

Agilent Technologies' total liabilities were at $5.99 billion at the end of 2025, a 0.6% increase from 2024, and a 80.9% increase since 2015.

In the past 10 years, Agilent Technologies' cash and equivalents has ranged from $1.05 billion in 2022 to $2.68 billion in 2017, and is currently $1.79 billion as of their latest financial filing in 2025.

Over the last 10 years, Agilent Technologies' book value per share changed from 12.57 in 2015 to 23.78 in 2025, a change of 89.1%.



Financial statements for NYSE:A last updated on 3/4/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners